Senolytic Drugs: New Strategy to Clear Senescent Cells
Senescent cell accumulation is a core mechanism of aging. Senolytic drugs can selectively clear senescent cells. Currently, 16 clinical trials are underway globally.
Life Science for Longer Life
We are dedicated to anti-aging drug research, tracking global clinical trial progress, and providing professional life science information.
Senescent cell accumulation is a core mechanism of aging. Senolytic drugs can selectively clear senescent cells. Currently, 16 clinical trials are underway globally.
Ξ²-Nicotinamide mononucleotide (NMN), as a NAD+ precursor, has 23 clinical trials globally, with 9 conducted in China.
As the most commonly used type 2 diabetes drug, metformin has been found to potentially have life-extending effects.